Difficulty: Medium
Average Score: 82%
Practice
After starting treatment for type 2 diabetes mellitus 6 months earlier, a patient is in the office for a follow-up examination. The nurse will monitor which laboratory test to evaluate the patient├óÔé¼Ôäós adherence to the antidiabetic therapy over the past few months?
Correct answer
B
Rationale
The correct answer is B: Hemoglobin A1C level. Hemoglobin A1C reflects average blood glucose levels over the past 2-3 months, providing a better assessment of long-term glycemic control. This is important in evaluating the patient's adherence to antidiabetic therapy over the past few months.
Choice A (Hemoglobin levels) is not as specific to monitoring diabetes control as Hemoglobin A1C. Choice C (Fingerstick fasting blood glucose level) provides a snapshot of glucose levels at a single point in time, not reflecting long-term control. Choice D (Serum insulin levels) does not directly measure the patient's adherence to antidiabetic therapy or overall glycemic control.
Choice A (Hemoglobin levels) is not as specific to monitoring diabetes control as Hemoglobin A1C. Choice C (Fingerstick fasting blood glucose level) provides a snapshot of glucose levels at a single point in time, not reflecting long-term control. Choice D (Serum insulin levels) does not directly measure the patient's adherence to antidiabetic therapy or overall glycemic control.